Seasonal Flu Vaccine Fluarix Approved for Children
The FDA has approved Fluarix, an inactivated seasonal influenza vaccine, for use in children ages 3 to 17 years. The vaccine was previously approved for adults.
In a study of more than 3000 children, those vaccinated with Fluarix had similar levels of antibodies to those given Fluzone, an approved pediatric flu vaccine. Side effects were similar to those seen with other flu vaccines.